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Abstract Stomach infection with pathogenic strains of Helico-
bacter pylori causes in some patients severe gastroduodenal
diseases. These bacteria produce various virulence factors and,
here, we review the recent acquisition on the biochemical mode of
action of three major factors. We discuss the role of urease both
as buffer of the stomach pH and as source of ammonia. The
vacuolating toxin alters the endocytic pathway of non-polarized
cells, inducing the release of acid hydrolases, the depression of
extracellular ligand degradation and of antigen processing and,
in the presence of ammonia, swelling of late-prelysosomal
compartments. In polarized epithelial monolayers, vacuolating
toxin induces an increase of the paracellular permeability,
independent of vacuolation. The neutrophil activating protein
induces the production of oxygen radicals in human neutrophils
and could contribute to the damage of the stomach mucosa. The
activities of these factors are discussed in terms of the need of the
bacterium of increasing the supply of nutrients from the stomach
lumen and from the mucosa.
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1. Introduction
The relevance of Helicobacter pylori for the pathogenesis of
gastritis and gastroduodenal ulcers has been proposed about
15 years ago [1,2] and the presence of this bacterium is now
established as the main risk factor in the development of
stomach carcinomas and lymphomas [3]. H. pylori infection
interests billions of people in the world, with peaks of 90% of
the population infected in countries with poor sanitary con-
ditions and a low socio-economical level. The circular genome
of H. pylori encodes about 1500 genes, depending on the
strain [4,5]. Several aspects of H. pylori infection and of the
host reactions have been uncovered and current research is
beginning to clarify the molecular mechanisms of action of
H. pylori virulence factors [6,7].
H. pylori is a spiral-shaped Gram-negative bacterium en-
dowed with a very powerful urease activity and with polar
£agella [8]. These features allow the bacterium to survive in
the stomach lumen. Urease activity bu¡ers the pH at the cell
surface, allowing bacterium survival until it enters the mucus
layer, a protective barrier against the high proton concentra-
tion (Fig. 1). H. pylori resides within the mucus and on the
apical surface of epithelial cells, as depicted in Fig. 1, where it
attaches ¢rmly via adhesin molecules and via modi¢cations of
cell membrane proteins and of cytoskeletal proteins [8^10].
This ecological niche ‘chosen’ by H. pylori requires special
features to survive, but o¡ers the advantage of little competi-
tion from other bacterial species.
Although H. pylori infections last for decades, only a mi-
nority of infected patients (15^25%) develop severe gastroduo-
denal diseases. Several factors contribute to this outcome
(diet, genetic factors, acid hypersecretion, stress etc.), but
the most important one is the virulence factor produced by
a given strain [7]. Major H. pylori factors are listed in Table 1
and available evidence indicates that pathogenic strains con-
tain a cluster of genes forming a pathogenicity island [11] in
addition to genes encoding a vacuolating toxin (VacA), a
neutrophil activating protein (HPNAP) and the urease.
2. VacA
The culture supernatants of about half of the H. pylori
isolates induce large cytoplasmic vacuoles in eukaryotic cells
[12], which eventually ¢ll up the entire cytosol, leading to cell
su¡erance. A protein toxin of 95 kDa, termed therefore VacA,
is responsible for such an activity [13]. Secondary structure
prediction programs indicate the presence of four distinct do-
mains within the VacA protein. A N-terminal signal sequence
necessary for export into the periplasm precedes a domain of
37 kDa (p37), predicted to contain K-helices and amphipatic
L-pleated segments, some of which are amphipatic. This do-
main begins with a 32 residues long hydrophobic segment and
ends with a protease-sensitive hydrophilic double repeat, fre-
quently cleaved in the VacA toxin released in the medium [14].
The following domain corresponds to a protein of 58 kDa
(p58), predicted to contain a ¢rst region with both K an L
secondary structures and a second region containing mainly
L elements, suggesting the existence of two sub-domains, pos-
sibly involved in di¡erent aspects of cell intoxication. The
second sub-domain exhibits a considerable genetic diversity,
whereas the ¢rst sub-domain is strongly conserved [15]. The
C-terminal part is similar to a bacterial domain capable of
translocating the rest of the molecule across the outer mem-
brane, which was ¢rst characterized in Neisseria gonorrhoeae.
After translocation, part of the 95 kDa protein is released
by selective proteolysis from the outer bacterial membrane
and it can be additionally cleaved within the repeat connecting
the p37 and p58 domains, which remain associated via non-
covalent forces [14]. The released toxin has a strong tendency
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to form £ower-shaped oligomers, composed of six or seven
monomers [16,17].
Oligomeric VacA is poorly active, but is strongly activated
by transient exposure to pH values 6 5.5 [18]. A low pH
induces monomerization with exposure of hydrophobic seg-
ments is likely to be involved in VacA penetration into the
lipid bilayer [17,19]. Little is known on the structural associ-
ation of the VacA molecules still bound to the outer mem-
brane of H. pylori. Surface-retained toxin may be as impor-
tant as the released oligomer, if not the predominant form in
vivo, as suggested by the recent ¢nding that the bacterium-
associated toxin is constitutively very active and does not
require pre-treatment at a low pH [20].
3. Cell vacuolation
In the presence of ammonium ions, VacA causes the rapid
appearance of small translucid vacuoles in the perinuclear
area of sparse cells in culture. Vacuoles contain membrane
protein markers of late endosomes (LEs) and of lysosomes
(LY) [21,22] and are accessible to extracellular £uid phase
markers as well as to BSA-gold pre-loaded inside LYs
([21,23,24], our unpublished results). Vacuoles are acidic be-
cause their limiting membrane contains the vacuolar ATPase
proton pump (V-ATPase), whose activity is essential for vac-
uole formation and enlargement [25,26]. They also contain
the small GTPase rab7 and an active rab7 is required for
vacuole biogenesis [27]. Electron microscopy reveals that vac-
uoles are largely devoid of the array of multivescicular bodies,
characteristic of LEs and LYs ([12,23,24 28] and our un-
published results).
Hence, it appears that VacA induces a reorganization of LE
and LY compartments, with extensive membrane fusion and
compartment swelling. Already in the early phases of such
alterations, before the development of large vacuoles, the fol-
lowing functional defects are evident, (i) a marked decrease of
the cell proteolytic activity within the endocytic pathway and
(ii) an extensive alteration of protein tra⁄cking from of the
trans network (TGN) to LE, as judged by the mistargeting of
acid hydrolases destined to LYs, which are released in the
extracellular medium. A partial pH neutralization of the lu-
men of LEs and LYs induced by VacA can account, or at
least contribute at early intoxication stages, for these e¡ects
[29]. Their consequences are likely to be directly relevant for
Fig. 1. Localization of H. pylori in the host. The bacterium is acquired via the oral route and survives the low pH of the stomach lumen be-
cause of the protective action of the urease, which bu¡ers the pH around the bacterial surface. The bacterium, propelled by powerful £agella
and helped by the helicoidal shape, penetrates into the mucus layer covering the super¢cial stomach cells. This layer is poorly permeable to bi-
carbonate anions, while it is very permeable to protons in the direction of the stomach lumen, but not vice versa [59,60]. As a consequence,
the pH above the cells is much less acidic than in the lumen. H. pylori adheres strongly to the apical cell surface via adhesins and VacA (Table
1) and induces a rearrangement of the underlying cytosol.
Table 1
Major virulence factors
Factor Function Distribution
Urease Bu¡ers stomach acid All strains
Flagella Motility All strains
NAP Neutrophil activation All strains
BabA Adhesin for Leb Prevalent on type I strains
VacA Cytotoxicity Most strains
PAI 31 Genes encoding type IV secretion system Type I strains
CagA Immunodominant antigen (part of PAI) Type I strains
PicB Equivalent to CagE Type I strains
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infection and disease pathogenesis. In fact, protein degrada-
tion is an essential function of the cell life, which allows the
removal of non-functional cell membrane proteins and of ex-
tracellular ligands and re-utilization of amino acids. More-
over, the processing of protein antigens is a selected hydrolysis
taking place mainly inside the antigen processing compart-
ment, which is a specialized form of LE/LY compartment,
capable of fusion with the plasma membrane [30]. VacA
was recently shown to inhibit the degradation of tetanus tox-
oid in the antigen processing compartment [31]. Consequently,
the stimulation of T-cell clones speci¢c for epitopes generated
in the antigen processing compartment was strongly inhibited
by VacA, while that of T-cell clones speci¢c for epitopes gen-
erated in the early compartment was una¡ected [31]. Such an
inhibition of antigen processing and presentation by VacA
may be part of a strategy of survival of H. pylori since a
depression of antigen processing within the mucosa would
signi¢cantly contribute to the long lasting infection that H.
pylori establishes in the human stomach. A second conse-
quence of the VacA-induced alteration of the LE/LY com-
partments is the release of lysosomal acid hydrolases which
are made in the ER as pre-pro-enzymes and are tagged in the
Golgi to be recognized by tag-speci¢c receptors, which drive
them from the TGN to LE and LY. Within these latter com-
partments, the pre- and pro- segments are removed with acti-
vation of their hydrolase activity [32]. If pre-pro-acid hydro-
lases are released on the acidic apical domain of the stomach
epithelial cells intoxicated by VacA, they can be converted
into the active form and thus degrade the protective mucus
layer depicted in Fig. 1. This degradation activity would co-
operate with H. pylori mucin degradating enzymes [33] in
decreasing the thickness of this layer (Fig. 1) with the possible
aim of increasing the supply of nutrients from the stomach
lumen to the bacterium.
Fig. 2. Hypothetical model of cell intoxication by VacA. The toxin is proposed to bind to the apical portion of epithelial cells via its carboxy-
terminal domain (p58) to a receptor (R), whose nature is still unidenti¢ed. Active monomeric toxin, but not oligomeric inactive complexes, in-
sert into the plasma membrane via hydrophobic protein-lipid interactions. The insertion step, which requires and involves the amino-terminal
domain (p37), results in the formation of anion-selective channels of a low conductance. These toxin channels are likely to result from re-as-
sembling of single toxin molecules into a new oligomeric structure (not pictured here). Endocytosis and transport to endosomes of the toxin, a
step which again requires p37, is proposed to increase the anionic permeability of these compartments, which in turn would enhance the vacuo-
lar ATPase proton pumping activity. In the presence of weak bases and in particular of the ammonia generated by the H. pylori urease, the en-
dosomal accumulation of osmotically active acidotropic ions (NH4 ) is predicted to increase. This leads to water in£ux and vesicle swelling, an
essential step in vacuole formation. Changes in the paracellular route of permeability of polarized epithelial cell monolayers might result from
a still unknown secondary mechanism, triggered by plasma membrane-associated channels. Alternatively, cytosol-delivered active portions of
VacA, formed by p37 plus an amino-terminal region of p58, would act on cell-cell junctions, to modify the trans-epithelial electrical resistance.
Such a putative cytosolic activity of the toxin could be of a catalytic nature and may play a role in vacuole formation as well.
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4. VacA induces an increase in the permeability of polarized
epithelial monolayers
H. pylori adheres strongly to the apical surface of the stom-
ach epithelial cells. Polarized epithelial monolayers maintain a
trans-epithelial electrical resistance (TER) which measures
their degree of sealing [34,35]. Low pH-activated VacA, added
apically, causes the rapid drop of TER from the initial value
to 1000^1500 Ohm/cm2, a low resistance state which is main-
tained for days [36]. Parallely, the paracellular route of per-
meability to small organic molecules and to ions such as Fe3
and Ni2, which are essential for H. pylori growth, is in-
creased. On the basis of these results, we suggest that the
major role of VacA is that of increasing the supply of essential
nutrients to the bacterium. The supply from the stomach lu-
men might increase indirectly via partial degradation of the
mucus layer, while the supply of nutrients from the mucosa
would result directly via loosening of the epithelial layer tight-
ness.
The increase of epithelial conductivity induced by the toxin
occurs in the absence of cell vacuolation, is not inhibited by
V-ATPase inhibitors and does not require weak bases, sug-
gesting that epithelial permeabilization induced by VacA is
distinct from vacuolization. The biochemical activity of
VacA is not known and it is also unknown whether it is a
membrane acting toxin or an A/B toxin acting intracellularly.
VacA transfected in HeLa cells induces vacuole formation [37]
and this activity is associated to the N-terminal domain
[38,39]. In addition, recombinant VacA p58 domain permea-
bilizes potassium-¢lled liposomes [40] and native VacA forms
anion-selective and voltage-dependent channels in planar lipid
bilayers only at a low pH or after low pH pre-activation [41].
These results may indicate that VacA is similar to diphtheria
toxin and related to three domain toxins with respect to the
cell entry process [42], but there is a major di¡erence. In fact,
VacA cell intoxication is clearly not inhibited by ammonium
ions, which prevent the membrane translocation of diphtheria
toxin from the endosomal lumen into the cytosol. This opens
the possibility that VacA can enter the cytosol from the plas-
ma membrane. If this were the case, VacA should form ion
channels on the plasma membrane of cells in culture after low
pH activation. Such a membrane permeabilization might be
taken as an indication that VacA is an A/B toxin and that it
re£ects a possible translocation step [42]. However, it might
also indicate that VacA acts via formation of an anion chan-
nel, a signi¢cant variation with respect to other known cyto-
solic acting toxins. As depicted in Fig. 2, formation of anion-
selective pores by VacA on the cell surface would lead to an
e¥ux of Cl3 and HCO33 from the cell cytosol into the extra-
cellular medium, thus causing a decrease in the intracellular
pH and contributing to cell intoxication. Moreover, such an
increased anionic permeability of the membrane is predicted
to favor, after endocytosis and targetting to the membrane of
LEs of VacA channels, the turn-over of the electrogenic V-
ATPase, thus increasing vacuolation by generation of an os-
motically driven water uptake in the endosomal vesicle [41].
5. HPNAP
H. pylori gastritis is characterized by in¢ltration of the in-
fected stomach mucosa by phagocytic in£ammatory cells
[1,2,43^45] and there is a good correlation between the degree
of mucosal damage and neutrophil in¢ltration [1,44^46]. A
protein capable of promoting neutrophil adhesion to endothe-
lial cells was identi¢ed in bacterial extracts [47]. The puri¢ed
protein is a 150 kDa oligomer composed of identical 15 kDa
subunits, with sequence similarities to bacterioferritins and
DNA binding proteins [48,49]. It was termed HPNAP because
of its capability of inducing neutrophils to produce reactive
oxygen radicals. Recombinant HPNAP stimulates the produc-
tion of reactive oxygen radicals via a cascade of intracellular
activation events, including an increase of the cytosolic calci-
um ion concentration and phosphorylation of proteins leading
to assembly of functional NADPH oxidase on the neutrophil
plasma membrane (Satin et al., in preparation). HPNAP as
neutrophil activator is however less powerful than PMA or
fMLP, which is in keeping with the suggestion that H. pylori
induces a moderate in£ammatory reaction leading to altera-
tion of the epithelial tight junctions and basal membranes
such as to promote the release of nutrients from the mucosa
to support the growth of H. pylori [8]. Such an activity of
HPNAP will add to the nutrient supply promoting activity
of VacA, discussed above. Alternatively, this may be an un-
necessary side activity of HPNAP, secondary to its main bio-
logical function, which remains to be determined.
6. Urease
Urease is an essential virulence factor which allows H. py-
lori to survive the very acidic conditions of the stomach lumen
before the bacterium swims into the mucus layer [50^52].
The biosynthesis of urease is governed by a seven gene
cluster which includes the genes encoding the UreA (26.5
kDa) and UreB (60.3 kDa) subunits of the urease and ¢ve
accessory proteins which are responsible for Ni2 uptake and
insertion into the active site of the apo-enzyme [53]. Urease is
a dodecameric protein composed of six UreA and six UreB
subunits arranged as a double ring of 13 nm diameter and the
residues involved in the coordination of the two active site
Ni2 ions are strictly conserved between H. pylori and Kleb-
siella aerogenes ureases [54].
Urease is synthesized without a leader sequence and accu-
mulates in the cytosol together with the heat shock protein
HspB, but these proteins are released upon bacterial autolysis
and adsorb e⁄ciently on the extracellular surface of viable
bacteria [55^57].
The urease may contribute to toxicity via the production of
ammonia, which is toxic to cells by itself and after reaction
with neutrophil metabolites, though the extent of this e¡ect in
vivo remains to be assessed. The picture is more de¢ned in in
vitro systems. In the presence of ammonium chloride, VacA-
induced vacuolization proceeds faster and vacuoles are larger
and swollen with respect to the vacuoles generated by the
toxin alone and to those induced by ammonia [23,28], which
suggests a substantial cooperation of urease and VacA in
damaging cells.
7. Cytotoxin associated gene A (CagA)
The cagA gene encodes a 128 kDa protein, an immuno-
dominant surface antigen always present in H. pylori strains
associated to the more severe form of diseases [7,11].
Although the function of CagA is not presently known, the
cagA gene is part of a large pathogenicity island which has
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been acquired by horizontal transfer of DNA [11]. The origin
of this pathogenicity island is not known but a di¡erence in
the GC content from the rest of the H. pylori genome indi-
cates that it has been acquired from another species or even
genus [58]. It includes at least 40 genes which are involved in
di¡erent pathogenic processes including the induction of in-
£ammatory mediators in gastric epithelial cells, induction of
pedestal formation and modi¢cation of intracellular signaling.
Similarities between some of these genes and genes of a
known function in other bacteria indicate that the pathogen-
icity island encodes a complex secretion system involved in the
release of macromolecules from the bacteria [11].
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